Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446206
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-05-22
Brief Title:
Adebrelimab Plus Chemotherapy Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer
Sponsor:
The First Hospital of Jilin University
Organization:
The First Hospital of Jilin University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-22
First Submit QC Date:
June 1 2024
Study First Post Date:
2024-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-01
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL